Takeda Pharmaceutical (TAK) Current Taxes (2018 - 2026)

Takeda Pharmaceutical's Current Taxes history runs 9 years deep, the most recent figure standing at $624.1 million for Q1 2026.

• In Q1 2026, Current Taxes fell 28.67% year-over-year to $624.1 million; the TTM figure through Mar 2026 stood at $624.1 million (down 28.67% YoY), while the FY2026 annual figure was $650.2 million, down 25.81% from the prior year.
• Current Taxes was $624.1 million for Q1 2026 at Takeda Pharmaceutical, down from $963.9 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $1.9 billion in Q2 2022 to a low of $624.1 million in Q1 2026.
• Historically, Current Taxes has averaged $1.2 billion across 5 years, with a median of $1.0 billion in 2024.
• Biggest YoY gain for Current Taxes was 37.88% in 2024; the steepest drop was 57.78% in 2024.
• A 5-year view of Current Taxes shows it stood at $1.3 billion in 2022, then slumped by 43.07% to $760.7 million in 2023, then surged by 37.88% to $1.0 billion in 2024, then slipped by 8.1% to $963.9 million in 2025, then slumped by 35.25% to $624.1 million in 2026.
• The last three Current Taxes figures came in at $624.1 million (Q1 2026), $963.9 million (Q4 2025), and $834.1 million (Q3 2025), per Business Quant data.